Celanese (CE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 May, 2026Executive summary
First quarter 2026 net sales reached $2.3 billion, up 6% sequentially, with a 5% volume increase and stable pricing, while net sales were $2,337 million, down 2% year-over-year due to lower volumes and pricing in Acetyl Chain, partially offset by currency impacts.
Achieved positive free cash flow in Q1 2026 for the first time since 2022, signaling a solid start to the year.
Operating profit increased 30% to $214 million, driven by a $50 million gain from the Micromax® business sale and cost savings in Engineered Materials.
Strategic actions included the restart of the Frankfurt VAM unit and the planned closure of the nylon 6,6 polymerization unit in Singapore.
Continued execution of cost reduction, deleveraging, and portfolio optimization initiatives, including significant divestitures and refinancing.
Financial highlights
Q1 2026 free cash flow was $3 million; adjusted EPS was $0.85.
Engineered Materials delivered $220 million in adjusted EBIT and $221 million in operating profit; Acetyl Chain delivered $131 million in adjusted EBIT and $95 million in operating profit.
Gross profit was $468 million, slightly down from $474 million year-over-year; operating margin improved to 9.2% from 6.9% year-over-year.
Cash and cash equivalents increased to $1.8 billion as of March 31, 2026.
Net cash provided by operating activities was $76 million, up from $37 million in Q1 2025.
Outlook and guidance
Q2 2026 adjusted EPS guidance is $2.00–$2.40, with Q2 expected to be the highest earnings quarter of the year.
Full-year free cash flow outlook raised to $700–$800 million.
Net debt to operating EBITDA ratio targeted to reach approximately 4.8x by year-end.
Management expects continued muted demand in key end markets, with ongoing focus on cost reductions and deleveraging.
Capital expenditures for 2026 are projected at $300–$350 million, prioritizing maintenance and productivity improvements.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2005 profit, but leverage and input-cost risks persisted.CE
Q4 2005 - Pricing and productivity lifted FY 2006 operating profit 30.3% to $747M.CE
Q4 2006 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - Recovery lifted sales and operating profit; 2011 growth was expected across all segments.CE
Q4 2010 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014